Emotional awareness therapy for fibromyalgia pain in people with lupus
Tests a talk therapy for widespread pain in adults with lupus.
Key facts
- Who runs it
- University of Utah
- Where
- Salt Lake City, United StatesSee the site
- Trial code
- Registry title
- Helping Lupus Patients Manage Fibromyalgia Symptoms Through Emotional Awareness and Expression Therapy (EAET)
- Status
- Recruiting
- People taking part
- 30 people, planned
- Started
- 1 Dec 2025
- Expected to end
- 4 Nov 2028
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Emotional Awareness and Expression Therapy (EAET)
- Record updated
- 29 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with lupus and fibromyalgia or chronic widespread pain who are on a stable medication regimen. It tests an online talking therapy for pain.
- Age
- 18 to 65 years
- Sex
- All genders can join.
- Disease stage
- Lupus together with fibromyalgia or chronic widespread pain, diagnosed by a licensed rheumatologist.
- Earlier treatment
- Must be on a stable medication regimen. Must not have changed medications in the past 3 months.
Main reasons for not taking part
- Serious psychiatric disorder not controlled with medications
- Active suicidal ideation
- Untreated alcohol or substance use disorder
- Substantial cognitive impairment
- Enrolled in another treatment study
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Adults of all genders, ages 18-65
- A diagnosis of lupus and fibromyalgia or chronic widespread pain by a licensed rheumatologist
- Be on a stable medication regimen
Who cannot take part
- Changes in medications in the past 3 months
- Serious psychiatric disorders (e.g., schizophrenia or bipolar disorder) uncontrolled with medications
- Untreated alcohol or substance use disorder
- Substantial cognitive impairment
- Failure to complete the baseline assessments
- Active suicidal ideation
- Enrollment in another treatment study
- Current involvement in health-related litigation or disability application
- Inability to use a computer and/or smartphone
- limited access to the internet
- Inability to communicate in English
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Where in United States
- University of UtahSalt Lake City, United StatesContact: Dan KaufmannTaking people
About the trial
What the trial wants to find out
The goal of this clinical trial is to learn if a psychotherapy intervention works to relieve widespread pain in patients with lupus. The main questions it aims to answer are:
Read full original descriptionShow less
Is the psychotherapy treatment safe for lupus patients? Are lupus patients able to complete the treatment? Can the treatment help improve chronic pain and other symptoms in lupus patients?
Researchers will compare the treatment to a control (participants who will continue their medical treatment but will not receive psychotherapy for the time frame of the treatment) to see if the psychotherapy treatment works to relieve widespread pain and other lupus-related symptoms.
Participants will:
Fill out questionnaires before and after the treatment. Participate in 8 weekly treatment sessions, 2 hours per session, delivered via Zoom from their own home.
Keep a list of medications and monitor any changes in their medication regimen.
The 2 groups in the trial
- Emotional Awareness and Expression TherapyTreatment being tested
The treatment will be conducted via HIPAA-compliant video telemedicine (Zoom) in small groups of patients for eight weekly sessions, 2 hours per session. Each session will use an educational lecture, discussion, in-class experiential exercises, and homework assignments. During sessions, participants will be encouraged to identify their stressors and experiences, and to express their avoided or suppressed emotions, using exercises such as emotional disclosure, role-playing, and the "empty chair" technique. Participants will be given homework assignments to complete between sessions, including expressive writing, identifying stressors and avoided emotions, and practicing healthy communication skills.
Treatment: Emotional Awareness and Expression Therapy (EAET)
- Wait list controlNo study treatment, for comparison
Participants assigned to the waitlist control condition will be assessed at baseline and at a time matched to EAET post-treatment. All interested participants will be offered the opportunity to receive the EAET treatment once their WL period is completed. Those who opt to receive the treatment will be required to complete another set of assessments post-treatment.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Evaluating the Feasibility and Efficacy of Emotional Awareness and Expression Therapy (EAET) on Fibromyalgia Outcomes in Patients With Systemic Lupus Erythematosus (SLE).
- Plain-language title
- Emotional awareness therapy for fibromyalgia pain in people with lupusGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT07282392, who can take part
- Record updated
- 29 December 2025